吉林省集安益盛药业股份有限公司

Core Viewpoint - The company has conducted its third quarterly board meeting and approved several key resolutions, including the financial report and the use of idle funds for investment in financial products [8][31][37]. Financial Data - The third quarter financial report has not been audited [7]. - The company plans to apply for a total of 5.7 billion yuan in loans from various banks to support its operational needs [9]. Shareholder Information - The company is addressing issues related to shareholding transparency, particularly concerning the shareholding of Liu Jianming, which is still under a holding arrangement [5]. - The company has developed a rectification plan to resolve the issues of shareholding representation and ensure accurate information disclosure [4]. Governance Changes - The board has approved the cancellation of the supervisory board and amendments to the company’s articles of association, which will be submitted for approval at the upcoming shareholder meeting [10][32]. - Various governance documents and rules have been revised and approved by the board, including those related to shareholder meetings and board operations [12][15][19]. Investment Strategy - The company intends to use up to 50 million yuan of idle funds to purchase financial products, aiming to enhance the efficiency of fund utilization while ensuring operational needs are met [37][43]. - The investment will focus on low-risk, high-liquidity financial products issued by banks and asset management companies [38].